Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1210/jc.2014-3421 http://scihub22266oqcxt.onion/10.1210/jc.2014-3421 C5393509!5393509!25590213     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Endocrinol+Metab 2015 ; 100 (2): 363-70 Nephropedia Template TP {{tp|p=25590213|t=2015. Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis |pdf=|usr=}}{{25590213}} gab.com Text Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis JO: J Clin Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=25590213 #FOAvip Context:: Various drugs affect body weight as a side effect. Objective:: We conducted this systematic review and meta-analysis to summarize the evidence about commonly prescribed drugs and their association with weight change. Data Sources:: MEDLINE, DARE, and the Cochrane Database of Systematic Reviews were searched to identify published systematic reviews as a source for trials. Study Selection:: We included randomized trials that compared an a priori selected list of drugs to placebo and measured weight change. Data Extraction:: We extracted data in duplicate and assessed the methodological quality using the Cochrane risk of bias tool. Results:: We included 257 randomized trials (54 different drugs; 84 696 patients enrolled). Weight gain was associated with the use of amitriptyline (1.8 kg), mirtazapine (1.5 kg), olanzapine (2.4 kg), quetiapine (1.1 kg), risperidone (0.8 kg), gabapentin (2.2 kg), tolbutamide (2.8 kg), pioglitazone (2.6 kg), glimepiride (2.1 kg), gliclazide (1.8 kg), glyburide (2.6 kg), glipizide (2.2 kg), sitagliptin (0.55 kg), and nateglinide (0.3 kg). Weight loss was associated with the use of metformin (1.1 kg), acarbose (0.4 kg), miglitol (0.7 kg), pramlintide (2.3 kg), liraglutide (1.7 kg), exenatide (1.2 kg), zonisamide (7.7 kg), topiramate (3.8 kg), bupropion (1.3 kg), and fluoxetine (1.3 kg). For many other remaining drugs (including antihypertensives and antihistamines), the weight change was either statistically nonsignificant or supported by very low-quality evidence. Conclusions:: Several drugs are associated with weight change of varying magnitude. Data are provided to guide the choice of drug when several options exist and institute preemptive weight loss strategies when obesogenic drugs are prescribed. Twit Text FOAVip Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis ????J Clin Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=25590213 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25590213 #FOAvip English Wikipedia <ref>{{Cite pmid|25590213}}</ref> Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis #MMPMID25590213 Domecq JP; Prutsky G; Leppin A; Sonbol MB; Altayar O; Undavalli C; Wang Z; Elraiyah T; Brito JP; Mauck KF; Lababidi MH; Prokop LJ; Asi N; Wei J; Fidahussein S; Montori VM; Murad MH J Clin Endocrinol Metab 2015[Feb]; 100 (2): 363-70 PMID25590213show ga Context:: Various drugs affect body weight as a side effect. Objective:: We conducted this systematic review and meta-analysis to summarize the evidence about commonly prescribed drugs and their association with weight change. Data Sources:: MEDLINE, DARE, and the Cochrane Database of Systematic Reviews were searched to identify published systematic reviews as a source for trials. Study Selection:: We included randomized trials that compared an a priori selected list of drugs to placebo and measured weight change. Data Extraction:: We extracted data in duplicate and assessed the methodological quality using the Cochrane risk of bias tool. Results:: We included 257 randomized trials (54 different drugs; 84 696 patients enrolled). Weight gain was associated with the use of amitriptyline (1.8 kg), mirtazapine (1.5 kg), olanzapine (2.4 kg), quetiapine (1.1 kg), risperidone (0.8 kg), gabapentin (2.2 kg), tolbutamide (2.8 kg), pioglitazone (2.6 kg), glimepiride (2.1 kg), gliclazide (1.8 kg), glyburide (2.6 kg), glipizide (2.2 kg), sitagliptin (0.55 kg), and nateglinide (0.3 kg). Weight loss was associated with the use of metformin (1.1 kg), acarbose (0.4 kg), miglitol (0.7 kg), pramlintide (2.3 kg), liraglutide (1.7 kg), exenatide (1.2 kg), zonisamide (7.7 kg), topiramate (3.8 kg), bupropion (1.3 kg), and fluoxetine (1.3 kg). For many other remaining drugs (including antihypertensives and antihistamines), the weight change was either statistically nonsignificant or supported by very low-quality evidence. Conclusions:: Several drugs are associated with weight change of varying magnitude. Data are provided to guide the choice of drug when several options exist and institute preemptive weight loss strategies when obesogenic drugs are prescribed. äDrugs Commonly Associated With Weight Change: A Systematic Review and (epmc).pdf DeepDyve Pubget Overpricing